New patent for Myovant Sciences drug MYFEMBREE

July 9, 2021 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for MYFEMBREE Myfembree is a drug marketed by Myovant Sciences and is included in one NDA. The generic ingredient in MYFEMBREE is estradiol; norethindrone acetate; relugolix.…

The post New patent for Myovant Sciences drug MYFEMBREE appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.